One Health, One Mission: The World Organisation for Animal Health on the AMR Frontline

An interview with Dr. Delfy Góchez.

FDA questions hypoglycemia risk for Novo Nordisk’s once-weekly insulin ahead of adcomm

The FDA is raising concerns about increased rates of hypoglycemia following treatment with Novo Nordisk’s experimental once-weekly basal insulin ahead of an advisory committee meeting

May 23, 2024

Clearmind Medicine Inc. Announces Pricing of $2.4 Million Registered Direct and Private Placement | Psychedelic Invest

Clearmind Medicine Inc. (NASDAQ: CMND) (the “Company”), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems,

January 11, 2024

Research highlights need for gender-specific diagnosis of heart failure in type 2 diabetes patients

A MedUni Vienna study has investigated gender-specific differences in the diagnosis of systolic heart failure in patients with type 2 diabetes.

August 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.